Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.14 +0.02 (+1.61%)
As of: Aug 21, 2026 · 10:52 AM EDT

Actinium Pharmaceuticals (ATNM) EBITDA Margin (QoQ) (2021 - 2022)

Actinium Pharmaceuticals (ATNM) EBITDA Margin (QoQ) (2021 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.96 Bn 132.11 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.79 Bn 78.79 Bn 3.93 Bn
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn
4 Moderna 60.20 Bn 55.06 Bn 52.00 Mn
5 BeOne Medicines 42.19 Bn 37.09 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.43 Bn 28.12 Bn 992.69 Mn
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.16 Bn 26.32 Bn -
10 Actinium Pharmaceuticals 35.74 Mn 35.74 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 -433,111.00
Jun 30, 2022 -1.69 Mn
Mar 31, 2022 3.44 Mn
Dec 31, 2021 -3.22 Mn
Sep 30, 2021 -86,850.00
Jun 30, 2021 -104,423.00